Millennium Management’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $144K | Buy |
54,092
+37,510
| +226% | +$100K | ﹤0.01% | 3774 |
|
|
2025
Q1 | $133K | Sell |
16,582
-115,322
| -87% | -$926K | ﹤0.01% | 3713 |
|
|
2024
Q4 | $1.27M | Sell |
131,904
-10,913
| -8% | -$105K | ﹤0.01% | 2758 |
|
|
2024
Q3 | $2.66M | Sell |
142,817
-476
| -0.3% | -$8.85K | ﹤0.01% | 2382 |
|
|
2024
Q2 | $2.38M | Buy |
143,293
+15,354
| +12% | +$255K | ﹤0.01% | 2385 |
|
|
2024
Q1 | $2.22M | Sell |
127,939
-41,801
| -25% | -$726K | ﹤0.01% | 2514 |
|
|
2023
Q4 | $2.65M | Buy |
169,740
+137,418
| +425% | +$2.15M | ﹤0.01% | 2314 |
|
|
2023
Q3 | $1.6M | Buy |
32,322
+22,986
| +246% | +$1.14M | ﹤0.01% | 2627 |
|
|
2023
Q2 | $730K | Buy |
9,336
+6,340
| +212% | +$496K | ﹤0.01% | 3086 |
|
|
2023
Q1 | $272K | Buy |
2,996
+1,827
| +156% | +$166K | ﹤0.01% | 3718 |
|
|
2022
Q4 | $138K | Buy |
+1,169
| New | +$138K | ﹤0.01% | 4217 |
|
|
2022
Q3 | – | Sell |
-762
| Closed | -$68K | – | 5645 |
|
|
2022
Q2 | $68K | Sell |
762
-5,455
| -88% | -$487K | ﹤0.01% | 4780 |
|
|
2022
Q1 | $965K | Buy |
6,217
+3,191
| +105% | +$495K | ﹤0.01% | 3615 |
|
|
2021
Q4 | $901K | Buy |
+3,026
| New | +$901K | ﹤0.01% | 3570 |
|
|
2021
Q3 | – | Sell |
-3,791
| Closed | -$1.72M | – | 5552 |
|
|
2021
Q2 | $1.72M | Buy |
+3,791
| New | +$1.72M | ﹤0.01% | 3294 |
|